Chemoembolisation with lipiodol and doxorubicin: Applicability in British patients with hepatocellular carcinoma

Gut

Volumn 38, Issue 1, 1996, Pages 125-128

  Ryder, S D ^a   Rizzi, P M ^a   Metivier, E ^a   Karani, J ^a   Williams, Roger ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Chemoembolisation; Doxorubicin; Hepatocellular carcinoma; Lipiodol

Indexed keywords

DOXORUBICIN; FLUOROURACIL; IODINATED POPPYSEED OIL; TAMOXIFEN;

ARTICLE; ARTIFICIAL EMBOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030030706     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.1.125     Document Type: Article

References (20)

1. Johnson PJ, Williams R. Hepatocellular carcinoma. Postgrad Med J 1979; 23: 100-9.
2. Takayashu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987; 162: 345-51.
3. Kanematsu T, Furuta T, Takenaka K, Matsumata T, Yoshida Y, Nishizaki T, et al. A 5 year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98-102.
4. Bronowicki J-P, Vetter D, Dumas F, Boudjema K, Bader R, Weiss A-M, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma. A four year study of 127 French patients. Cancer 1994; 74: 16-22.
5. Kasuagi H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized iol. Gastroenterology 1989; 97: 965-71.
6. Allison D, Jordan JH, Hennesy O. Therapeutic embolisation of the hepatic artery: a review of 75 procedures. Lancet 1985; i: 595-9.
7. Madden MV, Krige JEJ, Bailey S, Benningfield SJ, Geddes C, Werner ID, Terblanche J. Randomized trial of targeted chemotherapy with Lipiodol and 5′-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 1994; 34: 1598-600.
8. Farinati F, De Maria N, Fornasiero M, Salvagnini M, Fagiuoli S, Chiarmonte M, et al. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma. Dig Dis Sci 1992; 37: 659-62.
9. Elba S, Giannuzzi V, Misciagna G, Manghisi O. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma. Italian Journal of Gastroenterology 1994; 26: 66-8.
10. Cerezo FJM, Tomas A, Donoso L, Enriquez J, Guarner C, Balzano J, et al. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. J Hepatol 1994; 20: 702-6.
11. Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, et al. Percutaneous ethanol injected in the treatment of hepatocellular carcinoma in cirrhosis. A study of 207 patients. Cancer 1992; 69: 925-9.
12. Chen SC, Hsieh MY, Chuang WL, Wang LY, Chang WY. Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by arterial chemoembolization. J Gastroenterol Hepatol 1994; 9: 1-6.
13. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, et al. Transcatheter oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994; 19: 1115-23.
14. Ngan H, Lai CL, Fan ST, Lai ECS, Yuen WK, Tso WK. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam. Clin Radiol 1993; 47: 315-20.
15. Ikeda K, Kumada H, Saitoshi S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on survival time in patients with hepatocellular carcinoma: an analysis by the Cox proportional hazard model. Cancer 1991; 15: 2150-4.
16. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11: 181-4.
17. Group d'Etude et de Traitement du Carcinoma Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332: 1256-61.
18. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163: 387-94.
19. Yoshimi F, Nagao T, Inoue S, Kawano N, Muto T, Gunji T, et al. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial. Hepatology 1992; 16: 702-6.
20. Yu Y-Q, Xu D-B, Zhou X-D, Lu J-Z, Tang Z-Y, Mack P. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993; 71: 62-5.